Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

T3 Pharmaceuticals AG

T3 Pharma was founded in May 2015 as a spin-off of the University of Basel, Switzerland. The Company is focusing on immuno-oncology (bacteria-based) therapies for the treatment of solid tumors. Cancer immunotherapy is seen as a turning point in the fight against cancer. Unlike traditional therapies that attack the tumor directly, the goal of immunotherapies is to stimulate the immune system to selectively recognize and attack tumor cells. T3 is among the first companies supported by BaseLaunch. It was awarded «Science Startup of the year 2018» at Falling Walls Venture, won the Venture.ch business plan competition in 2016 and recently the W.A. de Vigier Award. *

 

Period Start 2015-05-01 established (s-off)
  Group Boehringer Ingelheim (Group)
  Predecessor University of Basel
Product Industry cancer immunotherapy (immuno-oncology, I-O)
Persons Person Ittig, Simon Josef (T3 Pharmaceuticals 201909 CEO + Co-Founder)
  Person 2 Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH)
     
Region Region Allschwil BL
  Country Switzerland
  Street 167A Hegenheimermattweg
Switzerland Innovation Park Basel Area
  City 4123 Allschwil BL
    Address record changed: 2023-11-22
     
Basic data Employees n. a.
     
    * Document for »About Section«: T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic".
     
   
Record changed: 2023-11-22

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top